| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A prospective, multicenter analysis of pseudocapsule characteristics: Do all stages of renal cell carcinoma have complete pseudocapsules?
|
Cho, Seok
|
|
2017
|
35 |
6 |
p. 370-378
|
artikel
|
| 2 |
Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score–matched study
|
Lee, Hakmin
|
|
2017
|
35 |
6 |
p. 379-385
|
artikel
|
| 3 |
Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol.September 2016;55:1–10.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 452-453
|
artikel
|
| 4 |
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer
|
Soria, Francesco
|
|
2017
|
35 |
6 |
p. 356-362
|
artikel
|
| 5 |
Characteristics of the peritumoral pseudocapsule vary predictably with histologic subtype of T1 renal neoplasms. Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS.Urology. November 2015;86(5):956–961.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 453-454
|
artikel
|
| 6 |
Do clear cell papillary renal cell carcinomas have malignant potential? Diolombi ML, Cheng L, Argani P, Epstein JI.Am J Surg Pathol. December 2015;39(12):1621–1634.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 451-452
|
artikel
|
| 7 |
Editorial Board
|
|
|
2017
|
35 |
6 |
p. i
|
artikel
|
| 8 |
Effect of statins as a secondary chemopreventive agent among individuals with non–muscle-invasive bladder cancer: A population-based analysis
|
Richard, Patrick O.
|
|
2017
|
35 |
6 |
p. 342-348
|
artikel
|
| 9 |
Enriching gene expression profiles will help personalize prostate cancer management for African-Americans: A perspective
|
Vijayakumar, Srinivasan
|
|
2017
|
35 |
6 |
p. 315-321
|
artikel
|
| 10 |
Expression pattern of immune checkpoint–associated molecules in radical nephrectomy specimens as a prognosticator in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
|
Hara, Takuto
|
|
2017
|
35 |
6 |
p. 363-369
|
artikel
|
| 11 |
Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
|
Liu, Yidong
|
|
2017
|
35 |
6 |
p. 349-355
|
artikel
|
| 12 |
GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma
|
Coric, Vesna M.
|
|
2017
|
35 |
6 |
p. 409-417
|
artikel
|
| 13 |
Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy
|
Moschini, Marco
|
|
2017
|
35 |
6 |
p. 335-341
|
artikel
|
| 14 |
Independent association between time to prostate-specific antigen (PSA) nadir and PSA progression-free survival in patients with docetaxel-naïve, metastatic castration-resistant prostate cancer receiving abiraterone acetate, but not enzalutamide
|
Miyake, Hideaki
|
|
2017
|
35 |
6 |
p. 432-437
|
artikel
|
| 15 |
Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma
|
Pal, Deeksha
|
|
2017
|
35 |
6 |
p. 401-408
|
artikel
|
| 16 |
Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma
|
Miura, Yuji
|
|
2017
|
35 |
6 |
p. 386-391
|
artikel
|
| 17 |
Masthead
|
|
|
2017
|
35 |
6 |
p. IFC
|
artikel
|
| 18 |
Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study
|
Levy, Isaiah
|
|
2017
|
35 |
6 |
p. 425-431
|
artikel
|
| 19 |
Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350–1355.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 450-451
|
artikel
|
| 20 |
Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma
|
Cohen, Andrew
|
|
2017
|
35 |
6 |
p. 322-327
|
artikel
|
| 21 |
Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database
|
Amini, Arya
|
|
2017
|
35 |
6 |
p. 438-446
|
artikel
|
| 22 |
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 449-450
|
artikel
|
| 23 |
Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer
|
Ramalingam, Sundhar
|
|
2017
|
35 |
6 |
p. 418-424
|
artikel
|
| 24 |
Quality indicators in the management of bladder cancer: A modified Delphi study
|
Khare, Satya R.
|
|
2017
|
35 |
6 |
p. 328-334
|
artikel
|
| 25 |
Table of Contents
|
|
|
2017
|
35 |
6 |
p. ii-iii
|
artikel
|
| 26 |
The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma
|
Zhang, Fan
|
|
2017
|
35 |
6 |
p. 392-400
|
artikel
|
| 27 |
The role of enhanced recovery in open or robotic cystectomy
|
Goonewardene, Sanchia Shanika
|
|
2017
|
35 |
6 |
p. 447
|
artikel
|
| 28 |
Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224–1231.
|
Kryvenko, Oleksandr N.
|
|
2017
|
35 |
6 |
p. 454-455
|
artikel
|
Tijdschrift beschrijving